Trials / Withdrawn
WithdrawnNCT00458445
A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators
A Phase IIIb Study to Evaluate the Efficacy and Time Course of Treatment With SPD465 Compared to Placebo on Simulated Driving Safety and Performance in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 19 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether SPD465 is safe and effective in the treatment of ADHD in young adult drivers after a duration of 16 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPD465 | |
| OTHER | Placebo | Placebo is a material that may look similar to SPD465, however, contains no active drug. |
Timeline
- Start date
- 2007-04-30
- Primary completion
- 2007-06-15
- Completion
- 2007-06-15
- First posted
- 2007-04-10
- Last updated
- 2021-07-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00458445. Inclusion in this directory is not an endorsement.